| EARNINGS PER SHARE Basic and diluted earnings per common share (“EPS”) for the three and six months ended June 30, 2026, and 2025, were: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | (in thousands, except per share data) | | Numerator: | | | | | | | | Net income (loss) | $ | 204,887 | | | $ | (492,282) | | | $ | 342,443 | | | $ | (332,179) | | | Denominator: | | | | | | | | Weighted average common shares outstanding - basic | 49,115 | | | 55,783 | | | 49,695 | | | 55,946 | | Plus: Dilutive effect of stock options and unvested restricted stock units | 513 | | | — | | | 469 | | | — | | Weighted average common shares outstanding - diluted | 49,628 | | | 55,783 | | | 50,164 | | | 55,946 | | | | | | | | | | Net income (loss) per common share: | | | | | | | | | Basic | $ | 4.17 | | | $ | (8.82) | | | $ | 6.89 | | | $ | (5.94) | | | Diluted | $ | 4.13 | | | $ | (8.82) | | | $ | 6.83 | | | $ | (5.94) | |
In the three and six months ended June 30, 2026, an insignificant number of outstanding shares issued under share-based compensation awards were anti-dilutive and therefore excluded from the calculation of diluted EPS. In the three and six months ended June 30, 2025, 0.5 million outstanding shares issued under share-based compensation awards were anti-dilutive and, therefore, excluded from the calculation of diluted EPS.
|